Neurology

Uzm. Dr. Ülgen Yalaz Tekan

Doctor and researcher Şişli Hamidiye Etfal Eğitim ve Araştırma Hastanesi İstanbul
Multiple Sclerosis
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyNeurologysaglik.gov.trFrom source
  • InstitutionŞişli Hamidiye Etfal Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workMultiple SclerosisExtracted from 3 publications · Model version —From source
  • Publications31 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0002-3448-7828ORCIDFrom source
  • Last synchronised5 November 2026 08:56https://sislietfaleah.saglik.gov.tr/TR-1435549/doktorlarimiz.html#ulgen-yalaz-tekansaglik.gov.tr

Scientific work

Publications on Multiple Sclerosis

31 publications

  1. Chronic neurological diseases with acute respiratory failure in a real-life cohort: insights into ICU and long-term survival—A retrospective study

    Journal of Clinical Neuroscience, 2026

    DOI 10.1016/j.jocn.2026.112228 PMID 42556002 Source: OpenAlex

  2. Understanding stigma in multiple sclerosis: workplace discrimination, social challenges and psychological impacts

    Acta Neurologica Belgica, 2026

    DOI 10.1007/s13760-025-02826-8 PMID 40553376 Source: ORCID

  3. Treatment Adherence in a Large Cohort of Turkish Multiple Sclerosis Population

    Neurological Sciences, 2025

    DOI 10.1007/s10072-025-08055-4 PMID 39971812 2 citations (Europe PMC) Source: ORCID

  4. Clinical characteristics and prognostic clinical factors of anti-gamma-aminobutyric acid-B receptor (GABAB-R) encephalitis in Türkiye: a multicenter study

    Neurological Research, 2025

    DOI 10.1080/01616412.2025.2495932 PMID 40314255 1 citation (Europe PMC) Open-access full textSource: ORCID

  5. Comparative Efficacy and Safety of Extended Versus Standard Interval Dosing of Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients: A Multicenter Analysis

    CNS Neuroscience & Therapeutics, 2025

    DOI 10.1111/cns.70445 PMID 40387571 1 citation (Europe PMC) Open-access full textSource: ORCID

  6. Understanding definitive and probable stroke-associated pneumonia: Risk factors and clinical outcomes

    Clinical Neurology and Neurosurgery, 2025

    DOI 10.1016/j.clineuro.2025.108770 PMID 39923495 2 citations (OpenAlex) Source: OpenAlex

  7. REFLEXES IN DEVELOPMENTAL ASSESSMENT

    Turkiye Klinikleri eBooks, 2025

    DOI 10.5336/978-625-395-672-1_p269 Source: OpenAlex

  8. the relationship between disease-related stigmatization and working life in multiple sclerosis patients

    Multiple Sclerosis Journal, 2024

    Source: ORCID

  9. Clinical and demographic characteristics of late-onset multiple sclerosis: LOMS-TR study

    Multiple Sclerosis and Related Disorders, 2024

    DOI 10.1016/j.msard.2024.105469 PMID 38341979 7 citations (Europe PMC) Open-access full textSource: ORCID

  10. Ensefalit Tanılı Hastalarda Ampirik Asiklovir Kullanımında Akut Böbrek Yetmezliği Gelişimi ve Mortalite ile ilişkisi

    Dicle Medical Journal / Dicle Tip Dergisi, 2024

    DOI 10.5798/dicletip.1552599 Open-access full textSource: OpenAlex

View all 31 publications